Seropositivity of chikungunya in hospital setting, India: A systematic review and meta-analysis

被引:0
作者
Nagarajan, Ramya [1 ]
Ayyasamy, Lavanya [1 ]
Ganeshkumar, Parasuraman [1 ]
Velusamy, Saravanakumar [2 ]
Murhekar, Manoj [2 ]
机构
[1] Indian Council Med Res Natl Inst Epidemiol, Div Noncommunicable Dis, Chennai, Tamil Nadu, India
[2] Indian Council Med Res Natl Inst Epidemiol, Div Infect Dis & Epidemiol, Chennai, Tamil Nadu, India
关键词
Chikungunya; meta-analysis; proportion; sero-positivity; systematic review; LABORATORY SURVEILLANCE; CLINICAL-FEATURES; VIRUS-INFECTION; DENGUE; COINFECTION; PRADESH; PROFILE; FEVER;
D O I
10.4103/ijcm.ijcm_63_24
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Backround:Information about the chikungunya disease burden by age groups and geographic distribution is necessary to guide appropriate control measures. With this, we conducted a systematic review and meta-analysis to estimate the disease burden of chikungunya fever in India.Material and Methods:We conducted this systematic review according to the Cochrane Collaboration guidelines. We retrieved relevant articles from PubMed and a free online search. Two investigators screened titles and abstracts and extracted data from the relevant articles. Our primary outcome is the proportion of laboratory-confirmed Chikungunya fever among clinically suspected patients. We used a random effect model to estimate the pooled proportion of Chikungunya fever.Result:A total of 20 articles were included in the quantitative syntheses. The pooled proportion of laboratory-confirmed chikungunya fever from 20 studies estimated using the random effects model is 24% (95%CI: 15-34%). We found the pooled proportion in the southern region was 35% (95%CI: 4-66%), 28% (95%CI: 3-58%) in the western region, 24% (95%CI: 1-48%) in the eastern region, 20% (95%CI: 12-29%) in the northern region, and 4% (95%CI: 1-6%) in North-eastern region.Conclusion:This review emphasizes the need to strengthen the surveillance of disease burden using multiple diagnostic tests and the need for an appropriate molecular diagnostic for early detection of the chikungunya virus.
引用
收藏
页码:805 / 811
页数:16
相关论文
共 40 条
[1]   Simultaneous detection of IgM antibodies against dengue and chikungunya: Coinfection or cross-reactivity? [J].
Abhishek, Kumar S. ;
Chakravarti, Anita .
JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2019, 8 (07) :2420-2423
[2]   Molecular characterization of dengue and chikungunya virus strains circulating in New Delhi, India [J].
Afreen, Nazia ;
Deeba, Farah ;
Khan, Wajihul H. ;
Haider, Shakir H. ;
Kazim, Syed Naqui ;
Ishrat, Romana ;
Naqvi, Irshad Hussain ;
Shareef, Mohammad Y. ;
Broor, Shobha ;
Ahmed, Anwar ;
Parveen, Shama .
MICROBIOLOGY AND IMMUNOLOGY, 2014, 58 (12) :688-696
[3]  
[Anonymous], Chikungunya fact sheet [Internet]. [cited 2021 Mar 31]
[4]  
[Anonymous], 2021, Critical appraisal tools JBI
[5]  
[Anonymous], Cochrane Handbook for Systematic Reviews of Interventions version 6.3 2022 [updated February 2022. 6.3:[Available from
[6]  
Arvind N, 2018, J PURE APPL MICROBIO, V12, P757, DOI [10.22207/JPAM.12.2.36, 10.22207/jpam.12.2.36]
[7]  
cdc, 2022, Prevention | Chikungunya virus | CDC
[8]  
Chikungunya: National Center for Vector Borne Diseases Control (NCVBDC), ABOUT US
[9]  
Chundawat B., 2013, JCDR
[10]   Hidden burden of chikungunya in North India; A prospective study in a tertiary care centre [J].
Dinkar, Anju ;
Singh, Jitendra ;
Prakash, Pradyot ;
Das, Arghya ;
Nath, Gopal .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2018, 11 (04) :586-591